CNXC or TRI: Which Is the Better Value Stock Right Now?

Zacks analysis identifies Concentrix Corporation (CNXC) as a superior value stock compared to Thomson Reuters (TRI) within the Business-Services sector. CNXC holds a Zacks Rank #2 (Buy) and an 'A' Value Grade, underpinned by significantly more attractive valuation metrics including a forward P/E of 4.14, PEG ratio of 0.57, and P/B of 0.72. In contrast, TRI has a Zacks Rank #3 (Hold) and an 'F' Value Grade, with higher multiples such as a 44.92 forward P/E, indicating CNXC's stronger earnings estimate revision activity and more favorable valuation for value-oriented investors.

Analysis

The comparative analysis between Concentrix Corporation (CNXC) and Thomson Reuters (TRI) strongly favors CNXC as the superior value investment within the Business-Services sector. This conclusion is primarily based on the Zacks rating system, which assigns CNXC a #2 (Buy) rank, indicating positive earnings estimate revision trends, compared to TRI's #3 (Hold) rank. The valuation disparity is stark: CNXC trades at a forward P/E of 4.14, a PEG ratio of 0.57, and a price-to-book (P/B) ratio of 0.72, suggesting it may be significantly undervalued relative to its growth prospects and book value. In contrast, TRI appears expensive with a forward P/E of 44.92, a PEG of 5.61, and a P/B of 6.18. These metrics culminate in CNXC receiving a top-tier 'A' grade for Value in the Zacks Style Scores system, while TRI receives a failing 'F' grade, reinforcing the quantitative case for CNXC's appeal to value-focused investors.

Key Decisions for Investors

• Value-oriented investors should consider Concentrix (CNXC) as a potential long position, given its strong 'Buy' rating and deeply discounted valuation metrics, including a forward P/E of 4.14 and a PEG ratio of 0.57.
• Investors holding Thomson Reuters (TRI) should re-evaluate their position in light of its 'F' grade for value and exceptionally high valuation multiples, which suggest significant downside risk if growth expectations are not met.
• Given the analysis hinges on the Zacks quantitative screening model, it is prudent to supplement this with qualitative due diligence on the specific drivers behind CNXC's positive earnings estimate revisions and the fundamental business outlook for both companies.